Gemtesa 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F57TG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,648
Award facts
- Contract value 100% obligated
- $47,647.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on January 28, 2026, for Gemtesa 75 mg tablets (30-count packaging) with a contract value of $47,647.71. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. This delivery order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent company is Cencora, Inc., which does business as AmerisourceBergen and holds the primary IDC relationship with DLA.
AmerisourceBergen's portfolio demonstrates its critical role in federal medical procurement, supplying an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies to support military treatment facilities and other government healthcare systems worldwide. The DLA Troop Support Medical contract enables the company to serve multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the military pharmaceutical supply chain. The ultimate completion date for this delivery order is January 29, 2026.
Quick answers
Who was awarded contract SPE2DR26F57TG?
SPE2DR26F57TG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F57TG worth?
The government has obligated $47,648 on SPE2DR26F57TG.
Is contract SPE2DR26F57TG an order under another contract?
Yes. SPE2DR26F57TG is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57TG competed?
The extent of competition for SPE2DR26F57TG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award